Catalyst Wire Dossier Catalyst Wire Dossier

exenatide ER

exenatide extended-release · Allergan plc (acquired by AbbVie)
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for exenatide ER, covering 2018-03-30 to 2018-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes [Phase 3]

See pricing